Aga Khan University Hospital conducts first prostate PET-CT scan - The Standard

-

Daniel Oguna, a PET CT technologist prepares a patient for a scan procedure at Aga Khan University Hospital, Nairobi. [Photo: Standard]

The latest and most advanced scan for evaluation of patients with prostate cancer is now available at the Aga Khan University Hospital, Nairobi. The Prostate-Specific Membrane Antigen (PSMA) PET CT scan has been available for only a few years and in the most advanced medical centres in the world.In a statement, the hospital said the scan allows for better treatment options of the disease while still in an early stage.In view of its higher sensitivity, this scan can identify sites of early prostate cancer spread before they are picked up by conventional imaging modalities.

SEE ALSO: Hospitals opt for staff pay cuts, unpaid leave

“This is bound to have a major impact on the successful outcomes of the treatment for those with prostate cancer,” a statement from the hospital read in part.Prostate Cancer PET-CT scan can detect the location and extent of cancer that has recurred after initial treatment and spread to other parts of the body. Prostate PET-CT scans can also detect cancer earlier than either CT scans alone or MRI scans.“Following advancement in our PET CT scan technology and growth in the expertise of our radiology and laboratory departments, AKUH, N is now able to produce the radioactive substance required for this scan as well as conduct the test,” the statement further stated.Prostate cancer causes at least 1,663 deaths every year out of 2,864 cases recorded.According to a report tabled in Parliament by National Cancer Institute of Kenya (NCI-K), Globocan 2018 estimates show that there are 47,887 new cases of cancer daily and 32,987 deaths annually.

SEE ALSO: How to stay safe as you seek care in hospitals

Compared to the presently established methods of imaging prostate cancer such as MRI and bone scan, PSMA PET CT scan has a higher sensitivity for identification of sites of prostate cancer spread, be it in the bones or in any other organs such as lymph nodes, liver and lungs.“It can be used for this purpose at the initial diagnosis of the disease, during follow-up and when disease recurrence is suspected,” the hospital said.It added: “The capacity to conduct this test adds to the expertise of our PET CT Scan and Cyclotron, a technology we acquired in 2018 at a cost of Sh600 million.”After the initial diagnosis of prostate cancer, patients undergo treatment such as surgery, cryotherapy or radiation. In some cases, cancer may recur. Following treatment, patients are monitored with periodic PSA blood tests.

Comments

Post a Comment

Popular posts from this blog

Cancer Glossary | Definitions & Phonetic Pronunciations

-
Image
mucositis treatment :: Article Creator Vitamins By Condition Learn about User Reviews and read IMPORTANT information about user generated content Conditions of Use and Important Information: This information is meant to supplement, not replace advice from your doctor or healthcare provider and is not meant to cover all possible uses, precautions, interactions or adverse effects. This information may not fit your specific health circumstances. Never delay or disregard seeking professional medical advice from your doctor or other qualified health care provider because of something you have read on WebMD. You should always speak with your doctor or health care professional before you start, stop, or change any prescribed part of your health care plan or treatment and to determine what course of therapy is right for you. This copyrighted material is provided by Natural Medicines Comprehensive Database Consumer Version. Information from this source i...
Read more

Sentinel lymph node biopsy: What cancer patients should know

-
Image
cancer lump on neck :: Article Creator Doctor Watching TV Show Spotted Cancer On Show's Guest That She Didn't Know About Say what you will about social media and daytime TV, but sometimes, they can help work wonders. In fact, the power of Facebook and the popularity of HGTV's Beachfront Bargain Hunt played a big part in helping Nicole McGuiness get ahead of her serious cancer diagnosis - but it was an eagle-eyed doctor who really saved her bacon. The then-32-year-old appeared on the property series alongside her father while in search of a holiday home in North Carolina to celebrate her recent recovery from brain cancer in May 2018. She explained that she had set her sights on 'something near the water', specifically a beachfront property in Morehead City, to start afresh in this new phase of her life. Dr. Erich Voigt was one of the viewers who tuned into the Beachfront Bargain Hunt episode, which Nicole featured in, an...
Read more

Expert Discusses Data From First Positive Trial for PARP Inhibitor in Prostate Cancer - Targeted Oncology

-
Image
Alan Bryce, MD PARP inhibition with olaparib (Lynparza) improved radiographic progression-free survival (rPFS) in heavily pretreated patients with metastatic castration-resistant prostate cancer (mCRPC) who had alterations in homologous recombination repair (HRR) genes, according to findings from the phase III PROfound trial presented at the 2019 ESMO Congress. This was the first positive randomized phase III trial reported evaluating a PARP inhibitor in men with mCRPC. The PROfound trial enrolled patients to 2 cohorts. In cohort A, 245 patients with  BRCA1/2  or  ATM  alterations, markers of HRR, were randomized 2:1 to receive either olaparib (n = 162) or physician’s choice of abiraterone acetate (Zytiga) with prednisone or enzalutamide (Xtandi) (n = 83). In cohort B, 142 patients with alterations in the  BARD1, BRIP1, CDK12, CHEK1/2, FANCL, PALB2, PPP2R2A, RAD51B/C/D , or  RAD54L , all of which are associated with HRR indirectly, were also randomized 2:...
Read more